Clinical Trial

"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.

Study acronym: HDV-Reflex
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the "Active Delta Referral" Project is to estimate the prevalence of anti-HDV positivity among HBsAg-positive patients hospitalized in the Department of Medicine at ASST Papa Giovanni XXIII in Bergamo, as well as among patients at the SerD and the Prison Healthcare Unit of the same ASST, following the introduction of the new methodology in 2025, and to compare these findings with existing estimates for outpatients.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-08-31 -> 2026-09-30 2026-07-10
Trial Details
NCT Number NCT07317011
Lead Sponsor FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Conditions Hepatitis, Delta
Enrollment 244 participants
Start Date 2025-10-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09